AcouSome | Acoustofluidic thin-film actuated chip for exosome separation from blood

Summary
AcouSome is a consortium stemming from the ongoing EIC-FET Open BioWings project, and consists of four of the BioWings project partners (AcouSort AB, DTU, Lund University and Day One Srl). AcouSome has the ambition to build on the disruptive technology of thin film actuated acoustofluidics developed in BioWings. The results obtained in BioWings will be combined with a polymer acoustofluidics technology developed in the ongoing Eurostars AcouPlast project to fabricate a polymer-based microfluidic chip for separating and enriching exosomes from blood for use in the next generation of point-of-care diagnostics.

Exosomes are nano-sized extracellular vesicles that are released by a significant number of different cell types. They are considered an important biomarker, with high diagnostic potential in a wide range of diseases, including different kinds of cancer (glioblastoma, melanoma, prostate cancer and many others), hepatitis, kidney, cardiovascular and liver diseases. Therefore, there is an increasing interest in exosomes as a powerful diagnostic tool. Having the opportunity to isolate and analyze exosomes from a routine blood test is crucial for early detection of a wide range of diseases.

In the AcouSome chip exosomes will be separated and enriched from blood by combining two steps already developed by Lund University and AcouSort. First plasma will be separated from blood by flowing the blood through a microfluidic channel, pushing the cells towards the centerline of the channel using ultrasoundand and subsequently splitting the cell and plasma flows. Exosomes will then be trapped and enriched from the plasma flow using a localized acoustic field. The acoustofluidic chip will be driven using thin-film actuators as invented together with DTU in the BioWings project. The exosome separation cartridge is intended for sample preparation in research labs and future diagnostic point-of-care instruments.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101099787
Start date: 01-01-2023
End date: 31-12-2025
Total budget - Public funding: 2 498 421,25 Euro - 2 498 419,00 Euro
Cordis data

Original description

AcouSome is a consortium stemming from the ongoing EIC-FET Open BioWings project, and consists of four of the BioWings project
partners (AcouSort AB, DTU, Lund University and Day One Srl). AcouSome has the ambition to build on the disruptive technology of
thin film actuated acoustofluidics developed in BioWings. The results obtained in BioWings will be combined with a polymer
acoustofluidics technology developed in the ongoing Eurostars AcouPlast project to fabricate a polymer-based microfluidic chip for
separating and enriching exosomes from blood for use in the next generation of point-of-care diagnostics.

Exosomes are nano-sized extracellular vesicles that are released by a significant number of different cell types. They are considered an
important biomarker, with high diagnostic potential in a wide range of diseases, including different kinds of cancer (glioblastoma,
melanoma, prostate cancer and many others), hepatitis, kidney, cardiovascular and liver diseases. Therefore, there is an increasing
interest in exosomes as a powerful diagnostic tool. Having the opportunity to isolate and analyze exosomes from a routine blood test
is crucial for early detection of a wide range of diseases.

In the AcouSome chip exosomes will be separated and enriched from blood by combining two steps already developed by Lund
University and AcouSort. First plasma will be separated from blood by flowing the blood through a microfluidic channel, pushing the
cells towards the centerline of the channel using ultrasoundand and subsequently splitting the cell and plasma flows. Exosomes will
then be trapped and enriched from the plasma flow using a localized acoustic field. The acoustofluidic chip will be driven using
thin-film actuators as invented together with DTU in the BioWings project. The exosome separation cartridge is intended for sample
preparation in research labs and future diagnostic point-of-care instruments.

Status

SIGNED

Call topic

HORIZON-EIC-2022-TRANSITIONOPEN-01

Update Date

09-02-2023
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2022-TRANSITION-01
HORIZON-EIC-2022-TRANSITIONOPEN-01 EIC Transition Open 2022